lumipulse alzheimer - Search News

Order byBest matchMost fresh

A Groundbreaking Alzheimer's Blood Test Is Now FDA-Approved

First blood test for Alzheimer's gets FDA greenlight: 3 things to know

The United States Food and Drug Administration recently cleared the first blood test to help diagnose Alzheimer’s disease.

· 7h

Best Life on MSN · 3d

FDA Approves First-Ever Alzheimer's Blood Test—Here's Who Will Benefit

· 1d

FDA approves first blood test to detect Alzheimer’s, marking major breakthrough

A Blood Test for Alzheimer’s: What to Know

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

· 1d

First Alzheimer’s Blood Test Available in US in June

· 2d

Common ailment linked to higher risk of Alzheimer’s disease: ‘Public health priority’

The Scientist2d

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.

Statement from the Alzheimer's Drug Discovery Foundation (ADDF) on FDA Approval of the First Blood Test to Aid in Alzheimer's Diagnosis

Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against Alzheimer's disease. This is the first blood test authorized to aid in the diagnosis of Alzheimer's—ushering in a new era of care,